当前位置： SCI文献检索 > BLOOD期刊下所有文献 > Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells.

Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells.

Abstract：

:The bone and immune systems are closely related through cellular and molecular interactions. Because bone-resorbing osteoclasts (OCs) are derived from the monocyte/macrophage lineage, similar to dendritic cells (DCs), we hypothesized that OCs could serve as antigen-presenting cells (APCs) to activate T cells. In this study, OCs were generated from human monocytes with stimulation by receptor activator of nuclear factor kappaB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). Results showed that, similar to DCs, OCs express major histocompatibility complex (MHC) classes I and II, and CD80, CD86, and CD40; and uptake soluble antigens. OCs secrete interleukin-10 (IL-10), transforming growth factor-beta (TGF-beta), IL-6, and tumor necrosis factor-alpha (TNF-alpha), but not IL-12p70. OCs present allogeneic antigens and activate both CD4+ and CD8+ alloreactive T cells in an MHC-restricted fashion. OCs also present soluble protein tetanus toxoid to activate autologous CD4+ T cells. These findings indicate that OCs can function as APCs and activate both CD4+ and CD8+ T cells. Thus, our study provides new insight into the effect of OCs on the immune system and may help develop novel strategies for treating diseases such as rheumatoid arthritis and multiple myeloma, which affect both the bone and immune systems.

journal_name

Blood

journal_title

Blood

authors

Li H,Hong S,Qian J,Zheng Y,Yang J,Yi Q

doi

10.1182/blood-2009-11-255026

subject

Has Abstract

pub_date

2010-07-15 00:00:00

pages

210-7

issue

2

eissn

0006-4971

issn

1528-0020

pii

blood-2009-11-255026

journal_volume

116

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.

    abstract：:Increased expression levels of miR-181 family members have been shown to be associated with favorable outcome in patients with cytogenetically normal acute myeloid leukemia. Here we show that increased expression of miR-181a and miR-181b is also significantly (P < .05; Cox regression) associated with favorable overall...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-10-386235

    authors： Li Z,Huang H,Li Y,Jiang X,Chen P,Arnovitz S,Radmacher MD,Maharry K,Elkahloun A,Yang X,He C,He M,Zhang Z,Dohner K,Neilly MB,Price C,Lussier YA,Zhang Y,Larson RA,Le Beau MM,Caligiuri MA,Bullinger L,Valk PJ,Del

    更新日期：2012-03-08 00:00:00

  • Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells.

    abstract：:Type I interferons (IFNs-alpha and IFN-beta) bind to a common receptor to exert strong antiproliferative activity on a broad range of cell types, including interleukin-6 (IL-6)-dependent myeloma cells. In this study, we investigated the effect of IFN-beta pretreatment on IL-6-stimulated mitogenic signaling in the huma...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Berger LC,Hawley RG

    更新日期：1997-01-01 00:00:00

  • Identification of early gene expression changes during human Th17 cell differentiation.

    abstract：:Th17 cells play an essential role in the pathogenesis of autoimmune and inflammatory diseases. Most of our current understanding on Th17 cell differentiation relies on studies carried out in mice, whereas the molecular mechanisms controlling human Th17 cell differentiation are less well defined. In this study, we iden...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2012-01-407528

    authors： Tuomela S,Salo V,Tripathi SK,Chen Z,Laurila K,Gupta B,Äijö T,Oikari L,Stockinger B,Lähdesmäki H,Lahesmaa R

    更新日期：2012-06-07 00:00:00

  • There's no such fool like an immunosenescent fool.

    abstract：:In this issue of Blood, Stepensky et al provide an astute description of immunosenescence arising from deficiency in tripeptidyl peptidase II (TPPII). Senescence of T and B lymphocytes is a striking finding, which has recently come into the limelight because it can be linked to primary immunodeficiency syndromes with ...

    journal_title：Blood

    pub_type： 评论,杂志文章

    doi：10.1182/blood-2014-12-614149

    authors： Seidel MG

    更新日期：2015-01-29 00:00:00

  • Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.

    abstract：:In an attempt to decrease the relapse rate after bone marrow transplantation (BMT) for advanced acute leukemia, we initiated studies using 131I-labeled anti-CD45 antibody (BC8) to deliver radiation specifically to hematopoietic tissues, followed by a standard transplant preparative regimen. Biodistribution studies wer...

    journal_title：Blood

    pub_type： 临床试验,杂志文章

    doi：

    authors： Matthews DC,Appelbaum FR,Eary JF,Fisher DR,Durack LD,Bush SA,Hui TE,Martin PJ,Mitchell D,Press OW

    更新日期：1995-02-15 00:00:00

  • Monoclonal antibody definition of T cell acute leukemia: a Pediatric Oncology Group study.

    abstract：:Leukemic blasts from 774 children with newly diagnosed acute lymphocytic leukemia (ALL) have been phenotyped by microcytotoxicity testing with a panel of monoclonal antibodies and heteroantisera as part of a Pediatric Oncology Group classification study of acute leukemia. One hundred twenty-two cases, or 16% were desi...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Borowitz MJ,Dowell BL,Boyett JM,Falletta JM,Pullen DJ,Crist WM,Humphrey GB,Metzgar RS

    更新日期：1985-04-01 00:00:00

  • Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.

    abstract：:A hamster antimouse CD3 monoclonal antibody (MoAb) opened the way to experimental studies on the suppression of allograft rejection and cytokine-related morbidity after treatment with antibodies modulating the CD3/T-cell receptor complex (CD3/TCR). Because earlier attempts to suppress graft-versus-host disease (GVHD) ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Mysliwietz J,Thierfelder S

    更新日期：1992-11-15 00:00:00

  • Evidence for a pretranslational defect in hereditary and acquired myeloperoxidase deficiency.

    abstract：:Myeloperoxidase (MPO) is a heme containing enzyme involved in the oxygen-dependent microbicidal activity of human polymorphonuclear leukocytes (PMN). Complete hereditary and acquired MPO deficiencies are defined as lack of peroxidase activity in PMN. Using this criterion, we studied a patient with complete hereditary ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Tobler A,Selsted ME,Miller CW,Johnson KR,Novotny MJ,Rovera G,Koeffler HP

    更新日期：1989-05-15 00:00:00

  • Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice.

    abstract：:Shiga-like toxin-1 (SLT-1) is a bacterial toxin that kills cells by inhibiting protein synthesis. SLT-1 is composed of one cytotoxic A-subunit and five B-subunits that bind to CD77, a cell-surface glycolipid. In the human hematopoietic system, CD77 expression is restricted to a subset of activated B cells and derived ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： LaCasse EC,Saleh MT,Patterson B,Minden MD,Gariépy J

    更新日期：1996-09-01 00:00:00

  • CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.

    abstract：:CCAAT/enhancer binding proteins (C/EBPs) are a family of factors that regulate cell growth and differentiation. These factors, particularly C/EBPalpha and C/EBPepsilon, have important roles in normal myelopoiesis. In addition, loss of C/EBP activity appears to have a role in the pathogenesis of myeloid disorders inclu...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2002-05-1374

    authors： Truong BT,Lee YJ,Lodie TA,Park DJ,Perrotti D,Watanabe N,Koeffler HP,Nakajima H,Tenen DG,Kogan SC

    更新日期：2003-02-01 00:00:00

  • Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis.

    abstract：:We investigated 17 patients (12 males and 5 females, ages 2 to 57 years old) with posttransfusion non-A, non-B hepatitis to determine relationships between clinical courses and hepatitis C virus (HCV) markers. The patients were grouped according to time course of abnormal serum alanine aminotransferase (ALT) levels in...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Shibata M,Morishima T,Kudo T,Maki T,Maki S,Nagai Y

    更新日期：1991-03-15 00:00:00

  • Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways.

    abstract：:The cyclin-dependent kinase inhibitor p21WAF1/Cip1 and Survivin enhance granulocyte macrophage colony-forming unit (CFU-GM) cell cycle and proliferation and have been implicated as antiapoptotic proteins. We investigated the relationships between p21 and Survivin in primary CFU-GM and c-kit+, lineage-negative (Lin-) c...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2003-05-1756

    authors： Fukuda S,Mantel CR,Pelus LM

    更新日期：2004-01-01 00:00:00

  • Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation")

    abstract：:Recently, we described a new genetic disorder (the "hereditary hyperferritinemia-cataract syndrome") clinically characterized by the combination of elevated serum ferritin and congenital bilateral nuclear cataract, both cotransmitted as an autosomal dominant trait. In affected subjects, hyperferritinemia (ranging from...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Girelli D,Corrocher R,Bisceglia L,Olivieri O,De Franceschi L,Zelante L,Gasparini P

    更新日期：1995-12-01 00:00:00

  • Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.

    abstract：:Perfluorocarbons have shown promise as clinical blood substitutes. Although early experience in Japan with one such product--Fluosol-DA--has been uncomplicated, we observed an adverse pulmonary reaction in the first American patient to receive it and know of similar reactions in two other Americans so treated. Postula...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Vercellotti GM,Hammerschmidt DE,Craddock PR,Jacob HS

    更新日期：1982-06-01 00:00:00

  • Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.

    abstract：:The bcl-2 gene is translocated into the Ig loci in about 80% of human follicular lymphomas and in 10% of B-type chronic lymphocytic leukemias (B-CLL), resulting in a high level of expression. We have compared the expression of bcl-2 transcripts and protein in B-CLL cells in their normal equivalent CD5+ B cells and in ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Schena M,Larsson LG,Gottardi D,Gaidano G,Carlsson M,Nilsson K,Caligaris-Cappio F

    更新日期：1992-06-01 00:00:00

  • Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.

    abstract：:Despite the importance of phosphoinositide 3-kinase (PI3K) in B-cell development, its activation mechanism still remains elusive. In this study, we show that deletion of both BCAP and CD19 leads to an almost complete block of BCR-mediated Akt activation and to severe defects in generation of immature and mature B cell...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-08-109769

    authors： Aiba Y,Kameyama M,Yamazaki T,Tedder TF,Kurosaki T

    更新日期：2008-02-01 00:00:00

  • Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel.

    abstract：:A single-stage disposable channel and seal that provides for leukocyte and granulocyte collection by continuous-flow cell separation (CFCS) has been designed by the IBM Corporation. This paper describes (1) the separation characteristics of whole blood as it responds to varying gravitational (G) forces and flow rates ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Hester JP,Kellogg RM,Mulzet AP,Kruger VR,McCredie KB,Freireich EJ

    更新日期：1979-07-01 00:00:00

  • Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens.

    abstract：:The use of 8-methoxypsoralen (8-MOP) and UV-A irradiation to inactivate contaminating donor leukocytes in platelet concentrates and to prevent primary alloimmunization against donor class I major histocompatibility (MHC) antigens in mice was investigated. CBA/CaH-T6J mice with the H2k haplotype and BALB/cByJ mice with...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Grana NH,Kao KJ

    更新日期：1991-06-01 00:00:00

  • Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN.

    abstract：:Hypomethylating agents (HMAs) improve survival in patients with higher-risk myelodysplastic syndromes (MDS) but are less well-studied in lower-risk disease. We compared the safety and efficacy of low-dose decitabine vs low-dose azacitidine in this group of patients. Adults with low- or intermediate 1-risk MDS or MDS/m...

    journal_title：Blood

    pub_type： 杂志文章,随机对照试验

    doi：10.1182/blood-2017-06-788497

    authors： Jabbour E,Short NJ,Montalban-Bravo G,Huang X,Bueso-Ramos C,Qiao W,Yang H,Zhao C,Kadia T,Borthakur G,Pemmaraju N,Sasaki K,Estrov Z,Cortes J,Ravandi F,Alvarado Y,Komrokji R,Sekeres MA,Steensma DP,DeZern A,Roboz G,

    更新日期：2017-09-28 00:00:00

  • Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine.

    abstract：:Nomifensine (Merital, Alival; Hoechst, Frankfurt, FRG), an antidepressant drug, may cause immune hemolytic anemia (IHA) of the so-called immune complex type that is believed to occur by means of an innocent-bystander mechanism. In this report we describe findings that are not consistent with this mechanism in a patien...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Salama A,Mueller-Eckhardt C

    更新日期：1986-12-01 00:00:00

  • Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6.

    abstract：:The response of megakaryocytes and platelets to the administration of recombinant human interleukin-6 (IL-6) was investigated in normal and sublethally irradiated dogs. IL-6 was administered for 2 weeks at doses of 10 to 160 micrograms/kg/d to normal animals to assess dose-response and toxicity. Subsequently, 40, 80, ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Burstein SA,Downs T,Friese P,Lynam S,Anderson S,Henthorn J,Epstein RB,Savage K

    更新日期：1992-07-15 00:00:00

  • Separation of erythroid progenitor cells in mouse bone marrow by isokinetic-gradient sedimentation.

    abstract：:Isokinetic-gradient sedimentation employing a shallow linear gradient of Ficoll in tissue culture medium was used to isolate erythroid progenitor cells (CFU-e) from mouse bone marrow. Following gradient sedimentation, 34% of the total nucleated cells and 48% of the CFU-e applied to the gradient were recovered, and thr...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Misiti J,Spivak JL

    更新日期：1979-07-01 00:00:00

  • A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.

    abstract：:Using urea-solubilized human fibrin monomer as an immunogen, we raised in mice a battery of monoclonal antibodies that reacted with the immunogen but not with urea-treated or native fibrinogen. Although they all failed to react with acid-solubilized fibrin monomer (acid-FM) alone, an antibody designated as IF-43 was f...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Soe G,Kohno I,Inuzuka K,Itoh Y,Matsuda M

    更新日期：1996-09-15 00:00:00

  • Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells.

    abstract：:We demonstrate here that EL4-6.1 cells, a mouse thymoma that expresses high levels of membrane interleukin (IL)-1 receptors, produce IL-1 beta as an autocrine regulatory factor. Endogenous IL-1 beta sustains both proliferation and apoptosis: during the exponential phase, it mainly promotes proliferation, while during ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Fratelli M,Gagliardini V,Galli G,Gnocchi P,Ghiara P,Ghezzi P

    更新日期：1995-06-15 00:00:00

  • Concomitant inactivation of Rb and E2f8 in hematopoietic stem cells synergizes to induce severe anemia.

    abstract：:The retinoblastoma (Rb) tumor suppressor plays important roles in regulating hematopoiesis, particularly erythropoiesis. In an effort to understand whether Rb function can be mediated by E2F transcription factors in a BM-derived hematopoietic system in mice, we uncovered a functional synergy between Rb and E2F8 to pro...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-10-388231

    authors： Hu T,Ghazaryan S,Sy C,Wiedmeyer C,Chang V,Wu L

    更新日期：2012-05-10 00:00:00

  • Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells.

    abstract：:Despite the remarkable efficacy of tyrosine kinase inhibitors (TKIs) in eliminating differentiated chronic myeloid leukemia (CML) cells, recent evidence suggests that leukemic stem and progenitor cells (LSPCs) persist long term, which may be partly attributable to cytokine-mediated resistance. We evaluated the express...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2012-12-475194

    authors： Nievergall E,Ramshaw HS,Yong AS,Biondo M,Busfield SJ,Vairo G,Lopez AF,Hughes TP,White DL,Hiwase DK

    更新日期：2014-02-20 00:00:00

  • Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.

    abstract：:Polycythemia vera (PV) is a clonal myeloproliferative disorder characterized by excessive erythrocyte production. Most patients with PV harbor an activating JAK2 mutation, but the molecular links between this mutation and erythrocyte overproduction are unknown. The interaction between death receptors and their ligands...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2005-07-3037

    authors： Zeuner A,Pedini F,Signore M,Ruscio G,Messina C,Tafuri A,Girelli G,Peschle C,De Maria R

    更新日期：2006-05-01 00:00:00

  • Identification of human megakaryocyte coagulation factor V.

    abstract：:Specific monoclonal and polyclonal antibody reagents and a double antigen indirect immunofluorescence microscopy technique were used to visualize coagulation factor V in human bone marrow. Marrow aspirates were smeared directly on glass slides, or washed and cytospun onto glass slides, or processed and plated into a p...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Nichols WL,Gastineau DA,Solberg LA Jr,Mann KG

    更新日期：1985-06-01 00:00:00

  • Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia.

    abstract：:The administration of interleukin-2 (IL-2) may induce complete remissions in acute myelogenous leukemia (AML) patients with a low proportion of residual bone marrow (BM) blasts. To confirm this preliminary observation, we treated 14 AML patients with advanced disease and with a residual BM blastosis that ranged betwee...

    journal_title：Blood

    pub_type： 临床试验,杂志文章

    doi：

    authors： Meloni G,Foa R,Vignetti M,Guarini A,Fenu S,Tosti S,Tos AG,Mandelli F

    更新日期：1994-10-01 00:00:00

  • Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.

    abstract：:Hereditary hemochromatosis is caused by mutations in the hereditary hemochromatosis protein (HFE), transferrin-receptor 2 (TfR2), hemojuvelin, hepcidin, or ferroportin genes. Hepcidin is a key iron regulator, which is secreted by the liver, and decreases serum iron levels by causing the down-regulation of the iron tra...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2009-09-245209

    authors： Gao J,Chen J,De Domenico I,Koeller DM,Harding CO,Fleming RE,Koeberl DD,Enns CA

    更新日期：2010-04-22 00:00:00